“Tripledemic” Survey Reveals Most Americans Are Confused by Testing Options
Allison McMullen, PhD, Scientific Partner for Molecular Diagnostics at Roche Diagnostics discusses a survey that shows that many Americans are confused ...
5345 articles
Allison McMullen, PhD, Scientific Partner for Molecular Diagnostics at Roche Diagnostics discusses a survey that shows that many Americans are confused ...
Arik Eisenkraft, MD., VP Clinical & Regulation at Biobeat, a digital tech company developing its proprietary data collection tools for remote patient mo...
David Harrell, Chairman and CEO of TranspareRX, the leading healthcare technology company bringing transparency to prescription drug pricing discusses C...
Cardiologists at Northwestern Medicine are using AI to identify patients with advanced heart failure who require specialized care, including those who m...
Deborah Young, director of the Division of Behavioral Research for the Kaiser Permanente Southern California Department of Research & Evaluation discuss...
Whether healthcare workers are on the front-line treating patients or working behind the scenes, the ability to successfully navigate change, rise above...
Anas Younes, Senior Vice President, Head of Haematology R&D, at AstraZeneca, discusses building a broad portfolio to target different hematological canc...
Therapy, in its many forms, has long been recognized as an essential tool in managing mental health, improving relationships, navigating life transition...
Jim Geraghty discusses rare diseases and his book "Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology.
Mary Dubon, Physical Medicine and Rehabilitation at Massachusetts General Hospital discusses her recent presentation at the American Academy of Physical...